Partnership Built with Purpose
Invest in the next generation of cannabis and plant based medicine companies.
Who is Your Cannabis Investment Officer?
It is likely cannabis and plant based medicines will be the best-performing asset class over the next decade. It is also unlikely that at the end of the decade one will be able to name an industry untouched by this plant.
MAZAKALI’s Outsourced Cannabis Investment Officer (OCIO) service leverages deep relationships, rigorous analytics, reliable research and uncommon pragmatism in support of a single goal: helping clients achieve their investment and impact objectives.
The MAZAKALI Digital Capital Platform
Investors come to us for direct placement opportunities as well as custom portfolio services provided by licensed investment advisors.
The MAZAKALI Digital Capital Platform provides a seamless online experience for investors and issuers to safely transact in a secure and supported fashion – investors can browse opportunities from around the world, execute investments, manage a portfolio and receive investor updates all within the platform.
The MAZAKALI Advantage
Every client is different. We work with family offices, accredited investors, RIAs and institutions who believe that purposeful investment in cannabis and plant based medicines can benefit not only their own portfolios but also the health of our plants, people and planet. Our clients are just as passionate about doing good as they are about doing well. See how we partner:
With Privilege Comes Responsibility
As early entrants and investment leaders, we are driven by a passion and belief that purposeful cannabis and plant based medicine investment will play a significant role Beyond Impact.
The MAZAKALI GreenPaper® has gained authority through knowledge on deep trends in the industry that matter to investors and operators alike.
MAZAKALI LLC (“MAZAKALI”) is an investment adviser registered with the state of California and is not a registered broker dealer. MAZAKALI’s principal, Sumit Mehta is an investment adviser representative of MAZAKALI and is also separately registered as an associated person of Growth Capital Services, Inc., a licensed broker-dealer and member of FINRA/SIPC (“GCS”), office of supervisory jurisdiction located at 582 Market Street, Suite 300, San Francisco, CA 94104. GCS and Mazakali are separate entities, and only certain securities brokered by Sumit Mehta are offered and sold through GCS. You can find more information about GCS and Mr. Mehta here and through FINRA Broker check.
Investment advisory services are provided exclusively from MAZAKALI’s San Francisco office. Registration as an investment adviser does not imply any particular skill or training. Any securities offered by Mr. Mehta are offered through GCS pursuant to an exemption from the registration requirements of the Securities Act of 1933, as amended (“Securities Act”), and such private placements are not subject to the disclosure requirements that apply to registered securities under the Securities Act. Unregistered securities, and investments in the cannabis industry in particular, are speculative, and considered by regulators to involve a high degree of risk. Any descriptions of securities or companies on the MAZAKALI website do not constitute a recommendation, solicitation, or investment advice by MAZAKALI, GCS or its registered representatives, including Mr. Mehta.
Any statements other than those of historical fact are estimates only, and not an indication of any future investment performance. Past performance is not a guarantee of future results. Moreover, none of MAZAKALI, GCS, or any of its registered representatives makes any representation, warranty or guaranty of any kind, express or implied, as to the accuracy, completeness or reasonableness of the information contained on the MAZAKALI website, or of any other written or oral communication transmitted or made available to any interested party.
Offerings and services may only be available to certain investor types, classes and/or groups, depending upon the type of offering, various regulatory requirements, and/or the preferences of the issuer and their advisers; including, but not limited to, limiting deal access or investment capability to accredited investors. In the most sensible investment strategy, alternative investments should only be part of your overall investment portfolio. Potential investors are advised to consult with their tax, legal and financial advisors before making any investment.